GFP
BIIB icon

Gryphon Financial Partners’s Biogen BIIB Stock Holding History

Gryphon Financial Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-217
Closed -$63K – 237
2018
Q2 		$63K Buy
217
+10
+5% +$2.81K 0.03% 187
2018
Q1 		$57K Sell
207
-25
-11% -$7.76K 0.03% 204
2017
Q4 		$74K Buy
+232
New +$74.4K 0.04% 177

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Gryphon Financial Partners's BIIB Position: Q3 2018 in Review

Gryphon Financial Partners sold out of Biogen (BIIB) in Q3 2018, closing a stake of 217 shares — an estimated $63K sold.

Gryphon Financial Partners first reported a position in BIIB in Q4 2017 and held it in 3 quarters. The position peaked at $74K in Q4 2017. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Gryphon Financial Partners reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 217 Biogen shares in Q3 2018, an estimated $63K.
  • Gryphon Financial Partners first reported a position in Biogen in Q4 2017 and held it in 3 quarters.
  • Gryphon Financial Partners's Biogen position peaked at $74K in Q4 2017.
  • 1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Gryphon Financial Partners's 13F filing for Q3 2018, filed 6 Nov 2018.